DiaMedica Therapeutics Inc（DMAC）價格預測

$6.450

+0.101 (+1.57%)收盤時

價格預測

1-Day Price Prediction

+0.18%

1-Week Prediction

-0.04%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

DMAC 相似圖表分析預測

Alphio's DMAC stock price prediction model matches the current DiaMedica Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.46 (+0.18%). The 1-week path is $6.45 (-0.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 DiaMedica Therapeutics Inc 股票嗎？

Currently, DMAC is not a strong buy due to its low RSI of 32.792, indicating oversold conditions, and a significant net loss of $10.1 million in Q2 2026. Although the stock has potential for recovery given its recent price fluctuations, the financial pressures and increasing R&D expenses pose risks.

DMAC 股價於 Tuesday 收在 $6.45，此前上漲 +1.57%

DiaMedica Therapeutics Inc (DMAC) last closed at $6.45, gaining +1.57%. These facts feed the 1-day and 1-week DMAC price prediction above.

預測驅動因素

DiaMedica Therapeutics Inc（DMAC）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 DMAC 最接近的股票，依相似度排序。

LGN

90.22%

-16.06%

HNST

89.89%

-6.37%

UEC

89.16%

+5.93%

APA

87.44%

-11.13%

BIDU

87.42%

+4.56%

DMAC 季節性分析

Historically the probability of a positive September return for DMAC is 90.48%. October offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…